Investors
To be an investor you must be a believer in a better tomorrow ~ Benjamin Graham
Hemera is a biotech company and an innovative start-up born with the aim of transforming scientific findings in the field of neuroregeneration into effective treatments, to bring research results to the patient bedside as soon as possible.
Hemera’s goal is to develop REMAST cell therapy as an advanced pharmacological product for the treatment of neurological lesions, transferring the therapy for spinal cord lesions conceived in the laboratories of the Universities of Verona and Milan into clinical practice.
Our ROADMAP
Fundraising according to Hemera
A new democratic form of investment aimed at raising the required capital from anyone who is interested in the development of new therapies for very disabling diseases and is looking for a truly socially responsible investment.
Since its foundation, in May 2021, the company has raised over 2 million euros.
In the first 18 months of the company’s life, 1 Family Office and over 100 business angels, private investors, and companies – who organized themselves into two investment syndicates called Friends of Founders S.r.l. and Proemera S.r.l. – invested in Hemera.